1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. Japan >
  6. Astellas Pharma >
  7. M&A

Astellas Pharma Mergers & Acquisitions

Astellas Pharma M&A Summary

Astellas Pharma has acquired 15 companies, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.

Astellas Pharma’s largest acquisition to date was in 2023, when it acquired IVERIC bio for $5.9B. It’s largest disclosed sale occurred in 2015, when it sold Astellas Pharma - Global Dermatology to LEO Pharma A/S for $761M. Astellas Pharma has acquired in 6 different US states, and 4 countries. The Company’s most targeted sectors include life science (87%) and medical products (7%).

M&A Summary

  • M&A Total Activity16
    • M&A Buy Activity15
    • M&A Sell Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 4

Astellas Pharma

Astellas Pharma, Inc.

2-5-1, Nihonbashi-Honcho Chuo-Ku,
Tokyo, 103-8411
Japan,
+81 3 3244 3000
www.astellas.com

All (16) Buy (14) Sell (2)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2023-11-15 Propella · Life Science
Pittsboro, North Carolina · www.propellatx.com

Propella is a biopharmaceutical company that has developed a platform that combines medicinal chemistry with lymphatic targeting to create best- or first-in-class oncology drugs that have validated MOAs and biological targets but suffer from efficacy and safety limitations. Lymphatic targeting enables therapies to be delivered directly to therapeutic target tissues including the lymph nodes and bone, thereby enhancing efficacy and bypassing plasma compartment safety and efficacy limitations and first-pass liver effects. Propella is based in Pittsboro, North Carolina.

Advisors: Cooley , Stifel 		- Add-on Acquisition

Astellas Pharma

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal